NCT02498717

Brief Summary

This study will examine the initial efficacy and cost-effectiveness of using the cryocompression therapy model both pre-operatively and post-operatively in patients that have recently suffered a traumatic calcaneus or ankle fracture compared to the standard pre-operative RICE therapy procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

June 3, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 15, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2017

Completed
Last Updated

February 15, 2018

Status Verified

February 1, 2018

Enrollment Period

1.7 years

First QC Date

March 31, 2015

Last Update Submit

February 13, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Time until surgery/Time until discharge (LOS)

    Reduction in length of stay (LOS) and time of effect (pre-/post-op)

    Measured from intake to time of surgery (days) and upon discharge from hospital (days). Estimated period of time to be up to 10 days until surgery and up to 7 days after surgery until discharge.

  • Change in Swelling as measured by point of largest swollen area (tape measure)

    Measured at circumference of swelling point

    Measured at baseline and all follow-up assessments (2, 8, 16, & 24-weeks post-op)

  • Total Narcotic Use as recorded on MR chart and Knee Pain Assessment

    reported as yes/no and amount/type on assessment form

    Measured daily while inpatient (approx 2-3 days) and retroactively at all follow-up assessments (2, 8, 16, & 24-weeks post-op)

  • Change in Patient reported pain as measured on VAS and Knee Pain Assessment

    As reported by VAS scale

    Reported at baseline, daily while inpatient (approx 2-3 days), and at all follow-up assessments (2, 8, 16, & 24-weeks post-op)

Secondary Outcomes (1)

  • Change in Quality of Life (QALY) as measured on QOL and SF-8

    At baseline and all follow-up assessments (2, 8, 16, & 24-weeks post-op)

Study Arms (2)

RICE (control)

ACTIVE COMPARATOR

Standard of Care procedures including ice and elevation.

Other: RICE

Cryocompression (experimental)

EXPERIMENTAL

treatment using the GameReady cryotherapy system

Device: GameReady

Interventions

GameReadyDEVICE

Cryotherapy and compression

Cryocompression (experimental)
RICEOTHER

SOC ice and elevation

RICE (control)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age
  • Able to provide informed consent
  • Recent calcaneus or ankle fracture requiring fixation
  • Injury is determined (by physician) to be an isolated, closed, low-energy bimalleolar fracture

You may not qualify if:

  • Unable to provide informed consent
  • History of Dementia or mental instability
  • No recent additional fractures (within one year) at or around injury site
  • Persons with symptoms of any kind of psychosocial disorder
  • Any condition that the clinician feels would contraindicate for the postoperative test or control treatments
  • Any conditions that would contraindicate using the Game Ready
  • If the patient is prevented from transfer to the OR due to reasons other than medically necessary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida Hospital

Orlando, Florida, 32804, United States

Location

MeSH Terms

Conditions

Ankle Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesAnkle InjuriesLeg Injuries

Study Officials

  • Brian Vickaryous, MD

    AdventHealth

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2015

First Posted

July 15, 2015

Study Start

June 3, 2015

Primary Completion

February 9, 2017

Study Completion

July 26, 2017

Last Updated

February 15, 2018

Record last verified: 2018-02

Locations